Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial
Not Applicable
- Conditions
- Dementia patients with BPSD
- Registration Number
- JPRN-UMIN000021562
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient who has an allergy to Sansoninto medicine. 2) Patients considered inappropriate by the study investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in neuropsychiatric inventory (NPI) score before and 4 weeks after sansonintotreatment
- Secondary Outcome Measures
Name Time Method Changes in neuropsychiatric inventory (NPI) subscale before and 4 weeks after Sansoninto treatment